| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 484.379 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 315.666 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 271.464 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 491.747 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 345.511 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 294.344 | 87 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 291.444 | 87 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 437.015 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 465.275 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 292.581 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 417.547 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 463.998 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 489.402 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 383.44 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 507.568 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 544.332 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 381.549 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 460.156 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 406.363 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 412.756 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 429.361 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 375.364 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 388.982 | 90 |